Integrin Beta 3 Market By Type (MSP-68, OCU-200, AC-301, C-16Y and Others), By Indication (Melanoma, Lung Cancer, Arterial Thrombosis and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI466421 | Publish Date: June 2023 | No. of Pages: 192

Global Integrin Beta3 Market Companies

  • Factor Therapeutics Ltd
  • Merck & Co Inc
  • SciFluor Life Sciences LLC
  • SOM Biotech SL
  • Vascular Pharmaceuticals Inc
  • VDDI Pharmaceuticals